CORTI NICOLÒ

Faltoni, M., Ricci, E., Mezzadri, L., Corti, N., Bisi, L., Fois, M., et al. (2025). Comparison of meropenem-vaborbactam vs ceftazidime-avibactam in the treatment of KPC producing Klebsiella pneumoniae infections. Intervento presentato a: ESCMID Global 2025. Congress of the European Society of
 Clinical Microbiology and Infectious Diseases, Vienna. Dettaglio

Mezzadri, L., Ricci, E., Merli, M., Corti, N., Faltoni, M., Bandera, A., et al. (2025). Ceftazidime-avibactam plus aztreonam versus cefiderocol in the treatment of infections caused by Metallo-β lactamase-Producing Microorganisms: real-word data from the Italian cohort SUSANA. Intervento presentato a: ESCMID Global 2025. Congress of the European Society of
 Clinical Microbiology and Infectious Diseases, Vienna. Dettaglio

Corti, N., Ricci, E., Faltoni, M., Mezzadri, M., Fois, M., De Vito, A., et al. (2025). Impact of cefiderocol therapy on patient survival across different multi drug-resistant Gram-negative bacilli infections: insights from the SUSANA cohort. Intervento presentato a: ESCMID Global 2025. Congress of the European Society of
 Clinical Microbiology and Infectious Diseases, Vienna. Dettaglio

Mezzadri, L., Corti, N., Ricci, E., Faltoni, M., Madeddu, G., Maggi, P., et al. (2024). Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections. Intervento presentato a: 33rd International Congress of Antimicrobial Chemotherapy (ICC), Istanbul. Dettaglio

Cavazza, G., Motto, C., Regna-Gladin, C., Travi, G., Di Gennaro, E., Peracchi, F., et al. (2024). Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management. ANTIBIOTICS, 13(5) [10.3390/antibiotics13050387]. Dettaglio